Viewing Study NCT05432505


Ignite Creation Date: 2025-12-25 @ 3:16 AM
Ignite Modification Date: 2025-12-31 @ 3:03 PM
Study NCT ID: NCT05432505
Status: UNKNOWN
Last Update Posted: 2022-06-27
First Post: 2022-06-21
Is NOT Gene Therapy: True
Has Adverse Events: False

Brief Title: Ligamentum Teres Tenodesis in Developmental Dysplasia of the Hip
Sponsor: Al-Azhar University
Organization:

Study Overview

Official Title: The Role of Ligamentum Teres Tenodesis in the Management of Developmental Dysplasia of the Hip
Status: UNKNOWN
Status Verified Date: 2022-06
Last Known Status: NOT_YET_RECRUITING
Delayed Posting: No
If Stopped, Why?: Not Stopped
Has Expanded Access: False
If Expanded Access, NCT#: N/A
Has Expanded Access, NCT# Status: N/A
Acronym: None
Brief Summary: The treatment of developmental dysplasia of the hip (DDH) remains challenging, yet recent advances have refined our understanding of how best to survey for the condition during infancy, minimize complications during early treatment, and refine the selection of patients who can best benefit from hip preservation surgery. The ideal continued target would be to prevent missed hip dislocations or dysplasia during the infant period, prevent avascular necrosis (AVN) during early treatment, and decrease the incidence of total hip arthroplasty in adulthood related to undertreated DDH, The goal of the treatment is to achieve a concentric reduction of the femoral head into the acetabulum.
Detailed Description: it is an operative technique to secure the femoral head after reduction in cases of developmental dysplasia of the hip

Operative technique:

The surgery will be accomplished under a general anesthesia.

An addition to the steps of the open reduction, the following were done:

1. Identification of ligamentum teres
2. ligamentum teres tenodesis

Study Oversight

Has Oversight DMC: False
Is a FDA Regulated Drug?: False
Is a FDA Regulated Device?: False
Is an Unapproved Device?: None
Is a PPSD?: None
Is a US Export?: None
Is an FDA AA801 Violation?: